Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Blinded, Multi-center Clincal Study of NGS-based Thyroscan Genomic Classifier in the Diagnosis of Thyroid Nodules

NCT05025046 is registered in ClinicalTrials.gov with Rigen Biotech as lead sponsor.

NCT NCT05025046
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05025046 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Blinded, Multi-center Clincal Study of NGS-based Thyroscan Genomic Classifier in the Diagnosis of Thyroid Nodules
Lead sponsor
Rigen Biotech
Phase
Observational
Overall status
Completed
Start date
September 1, 2021
Completion date
December 31, 2024
Enrollment
250 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

thyroid cancer, thyroid nodule